Seki Drops 25ml 35.4mg/ml,Seki Gocce 25ml 35,4mg/ml,ZAMBON ITALIA SRL

“ACTIVE substances: 10 mg film-coated tablets: cloperastina hydrochloride 10 mg. 35.4 mg/ml g Western oral suspension: 100 ml contain cloperastina fendizoato 3.5 4 g in the amount of cloperastina 1.8 g; 1 drop (equivalent to 0.05 ml) contains 1.8 mg of cloperastina fendizoato in the amount of 0.9 mg of cloperastina. Ba mb 4.4 mg chewable tablets: cloperastina fendizoato 4.4 mg.
Excipients: 10 mg film-coated tablets: microcrystalline cellulose, silicon dioxide, talc, magnesium stearate, hypromellose, povidone, macrogol 4000, sucrose, m agnesio carbonate, titanium dioxide, eritrosina (E127). 35.4 mg/ml oral drops, suspension: poliossietilene stearate, silicon dioxide, methyl-p-id rossibenzoato, sucrose, banana flavor, purified water. Children 4.4 mg chewable tablets: sucrose, mannitol, microcrystalline cellulose, starch, methylcellulose, magnesium stearate, talc, frag ol essence.
INDICATIONS: cough medicine.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active substance and to any of the ingredients.
DOSAGE: daily dose. Adults. Film-coated tablets: 2 tablets in the evening before bedtime; 1 tablet in the morning, 1 tablet in the afternoon or, preferably, between meals. Drops: 30 drops in the evening before bed, Arsi, 15 drops in the morning, 15 drops in the afternoon. Children. Chewable tablets. Up to 7 years: 2 tablets in the evening before bed; one tablet in the morning; tablet in the afternoon. After 7 an ni: 4-6 tablets in the evening before bedtime; 2-3 tablets but ctive; 2-3 tablets in the afternoon. Drops: 14 drops, in the evening before c oricarsi, 8 drops in the morning, 8 drops in the afternoon. Under two years of age: Doses are proportional to minors.
STORAGE CONDITIONS: Drops and chewable tablets: this medicine does not require any form of administration, especially preservation. Film-coated tablets: store at a temperature not exceeding 25 degrees C.
WARNINGS: Sucrose: Tablets contain 48 mg sucrose per dose; c ompresse chewables contain approximately 36.8 mg of sucrose per dose; drops contain approximately 140 mg of sucrose per ml. Patients aff TV with rare hereditary problems of fructose intolerance, from glucose-galactose malass or deficiency in sucrase isomalt asi, should not take this medicine. In the case of subjects on diabase or who follow a low-calorie diet, it is worth considering that the drug contains sugar. The drops also contain paraidr ossibenzoati (E218 and E216), which can cause delayed allergic reactions.
INTERACTIONS: Interaction studies have not been conducted in humans. It is not recommended, given both adult patients and children, simultaneous use with: lcool, antihistamines, anticholinergics, sedatives. It is not known if the degree of interaction in pediatric age is greater than that in adulthood. Does not contain information about the need for drug interactions using laboratory tests. There are no data or data available regarding the interaction of cloperastina with food, so administration with food is not recommended.
SIDE EFFECTS: Common effects in indesign: very common (>= 1/10); general (>= 1/10 0, = 1/1000, = 1/10000,
PREGNANCY AND BREAST-FEEDING: There is no information available on the use of Seki in pregnant nza. Although toxicity studies conducted during pregnancy in animals have not shown teratogenic and fetal ssicita activity, and it is a good prudential rule not to take the drug in the first months of pregnancy and in the subsequent period only in the case of actual VAT necessary under the direct supervision of a physician. It is not known if the drug and/or its metabolites are excreted in breast milk; a little ‘iche’ cannot exclude a risk to the nursing baby, should not be used during breastfeeding.”